Skip to content
Free shipping and returns
  • About SUDOSCAN®
  • Our Company
  • Medical Articles
  • Approved Cleaning Products
  • Media & Events
  • Contact Us
  • SUDOSCAN® Shop
  • Log in
  • YouTube
  • LinkedIn
Cart
Subtotal
$0.00
Shipping, taxes, and discount codes calculated at checkout.
Your cart is currently empty.
Refundable Security Deposit for Sudoscan Refundable Security Deposit for Sudoscan Sudoscan Logo white Sudoscan Logo white
  • About SUDOSCAN®
  • Our Company
  • Medical Articles
  • Approved Cleaning Products
  • Media & Events
  • Contact Us
  • SUDOSCAN® Shop
account Log in icon-bag-minimalCart
Access Denied
IMPORTANT! If you’re a store owner, please make sure you have Customer accounts enabled in your Store Admin, as you have customer based locks set up with EasyLockdown app. Enable Customer Accounts
Home / Media & Events / Detection of Diabetic Foot Risk: EASD 2019 Poster Presentation
Diabetes · Events · News · Scientific publications · Feb 18, 2023

Detection of Diabetic Foot Risk: EASD 2019 Poster Presentation

Detection of Diabetic Foot Risk: EASD 2019 Poster Presentation

A multi-center study (3 hospitals: Bichat, La Pitié Salpêtrière, Bégin) completed in France established the link between the grade of diabetic foot risk and the decrease of Electrochemical Skin Conductance (ESC) measured with SUDOSCAN.
A poster has been presented at the European Association for the Study of Diabetes (EASD) conference in September 2019 (1).

Percentage of neuropathies and severe neuropathies in patients with diabetes classified according to the gradation of diabetic foot risk.

Moreover, in a recent report, the French health department (HAS, Haute Autorité de Santé) has recommended that patients with diabetes be referred to podiatrists for prevention of foot lesions starting as soon as grade 1 foot risk (2).

References:
(1) Travert F, Sollier M, Potier L, Bianchi L, Gubranski G, Debbah E, Garcia C, Kadouch D, Dolz M, Allain J, Hansel B, Marre M, Bordier L, Roussel R. Lesions of the small fibers of the autonomic nervous system and gradation of the diabetic foot risk in patients with diabetes. Poster EASD 2019.
(2) HAS Argumentaire. Évaluation des actes réalisés par le pédicure-podologue pour la prévention des lésions, des pieds à risque de grade 1, chez le patient diabétique. Actualisation de l’évaluation conduite en 2007. Décembre 2018.

Share Share on Facebook Share Tweet on X Pin it Pin on Pinterest

icon-left-arrow Back to Media & Events
Invalid password
Enter
Sudoscan Logo

SUDOSCAN® is a privately-owned French medical device company.

Created in June 2005, SUDOSCAN is located in San Diego, CA, USA; the company's corporate headquarters are in Paris, France. We service all of the North and South America, The Middle East, Europe and Asia.

  • YouTube
  • LinkedIn

Sudoscan

  • About SUDOSCAN®
  • Our Company
  • Medical Articles
  • Approved Cleaning Products
  • Media & Events
  • Contact Us
  • SUDOSCAN® Shop

Shop SUDOSCAN

  • Login
  • Create account
  • SUDOSCAN® Shop

Resources

  • For Physicians
  • Reimbursement Regulatory
  • Approved Cleaning Products
  • For Patients
  • SUDOSCAN® Videos
  • SUDOSCAN® Image Gallery
  • SUDOSCAN® Articles

CONTACT INFO:

US TERRITORIES:
SUDOSCAN Inc.
8525 Gibbs Dr. Suite 304
San Diego, CA 92123

Phone: +1 858 450 2800

INTERNATIONAL:
Impeto Medical
2 Rue Maurice Hartmann,
92130 Issy-les-Moulineaux,
France

Phone: +33 (0)7 87 20 32 03
Website: www.sudoscan.com

Promotional Communication. The medical devices SUDOSCAN® is cleared by the US Food and Drug Administration (FDA). The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 05/10/2023

  • American Express
  • Diners Club
  • Discover
  • Mastercard
  • Visa
© 2025 SUDOSCAN USA | Autonomic & Sudomotor Testing Device Powered by Shopify
Detection of Diabetic Foot Risk: EASD 2019 Insights